23291-87-4 Usage
Uses
Used in Pharmaceutical Research:
2-METHYL-3H-BENZOIMIDAZOL-5-YLAMINE is used as a research compound for exploring its potential biological activities and therapeutic applications. Its unique chemical structure and properties make it a valuable candidate for the development of new drugs to treat a range of diseases.
Used in Drug Development for Cancer Treatment:
In the pharmaceutical industry, 2-METHYL-3H-BENZOIMIDAZOL-5-YLAMINE is used as a starting material or a key intermediate in the synthesis of anticancer agents. Its potential biological activities suggest that it may contribute to the development of new drugs for the treatment of various types of cancer.
Used in Drug Development for Inflammatory Diseases:
2-METHYL-3H-BENZOIMIDAZOL-5-YLAMINE is also used in the development of drugs for the treatment of inflammatory diseases. Its potential to modulate biological pathways involved in inflammation makes it a promising candidate for the creation of new therapeutic agents.
Used in Drug Development for Neurological Disorders:
In the field of neurological research, 2-METHYL-3H-BENZOIMIDAZOL-5-YLAMINE is used as a compound of interest for the development of drugs targeting neurological disorders. Its potential to interact with specific biological targets associated with these conditions positions it as a candidate for further investigation and therapeutic use.
Overall, 2-METHYL-3H-BENZOIMIDAZOL-5-YLAMINE's diverse applications in the pharmaceutical and medicinal chemistry fields highlight its potential as a versatile compound for addressing various health challenges.
Check Digit Verification of cas no
The CAS Registry Mumber 23291-87-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,2,9 and 1 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 23291-87:
(7*2)+(6*3)+(5*2)+(4*9)+(3*1)+(2*8)+(1*7)=104
104 % 10 = 4
So 23291-87-4 is a valid CAS Registry Number.
23291-87-4Relevant academic research and scientific papers
Hydrogenation on palladium-containing granulated catalysts 3. Synthesis of aminobenzimidazoles by catalytic hydrogenation of dinitroanilines
Elkin,Tolkacheva,Chernysheva,Karmanova,Konyushkin,Semenov
, p. 1216 - 1226 (2008/09/19)
Efficient hydrogenation of o-aminonitrobenzenes on palladium-containing granulated carbon catalysts in carboxylic acid solutions was accompanied by cyclization into aminobenzimidazoles. A simple hydrogenation reactor with a fixed gauze holding a reusable granulated catalyst was designed. Acylated and sulfonylated 4(7)-aminobenzimidazoles were obtained. In terms of electronic and geometrical parameters, they are close analogs of biologically active imidazo[1,5,4-e,f ][1,5]benzodiazepines.
